• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Slide deck: COVID-19 – Epidemiology in Canada (March 11, 2022)

March 11, 2022
Recommend to a Colleague print
 

Summary of epidemiology, cases and mortality rate; Canada and world statistics.

Download COVID-19 slide deck

TOPICS: COVID-19
Recommend to a Colleague

Related Posts

  • Effectiveness of COVID boosters in MS: an update
    November 30, 2022
  • ECTRIMS 2022 HIGHLIGHTS – SATURDAY, OCTOBER 29 EDITION
    October 29, 2022
  • ECTRIMS 2022 HIGHLIGHTS – THURSDAY, OCTOBER 27 EDITION
    October 27, 2022
  • Bivalent COVID booster approved in Canada
    September 16, 2022
  • COVID-19 and MS – updated findings
    July 28, 2022
Go back to home page

Browse by Topic

MS (332)
AD (81)
PD (77)
COVID-19 (58)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)
SCHIZOPHRENIA (25)
STROKE (22)
EPILEPSY (21)
ECTRIMS 2015 (13)
Library (13)
AAN 2015 (11)
ECTRIMS 2019 (10)
ECTRIMS 2021 (10)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2018 (9)
MS SEQUENCING (9)
ECTRIMS 2013 (9)
AAN 2014 (9)
AAN 2013 (9)
CLINICAL CASES IN MS (8)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
ECTRIMS 2017 (6)
CHARCOT 2013 (6)
AAN 2021 (6)
ECTRIMS 2022 (6)
ECTRIMS 2016 (5)
CCSVI (5)
BIPOLAR (5)
ANXIETY (5)
AAN 2022 (5)
NeuroSound (4)
BPD (4)
EAN 2015 (4)
AAN 2020 (3)
PAIN (3)
EAN 2022 (3)
AAN 2017 (3)
ENS 2013 (3)
SPECIAL REPORT (2)
EAN 2020 (2)
NEW DRUGS (2)
SLEEP (2)
APA 2014 (2)
AAN 2018 (2)
hATTR (1)
LUMBAR PUNCTURE (1)
LGS (1)
GUIDELINES (1)
ACTRIMS 2022 (1)
SEIZURE (1)
ALS (1)
EAN 2021 (1)
TSC (1)
APA 2016 (1)
INSOMNIA (1)
AAN 2016 (1)
Dravet syndrome (1)
CIDP (1)
CONCUSSION (1)
ADDICTION (1)
WEST NILE (1)
EAN 2019 (1)
EAN 2016 (0)
ECTRIMS 2020 (0)
View all Topics

Popular Posts

  • The end of MS phenotypes? posted on January 26, 2023
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Progression independent of relapses (PIRA) in MS posted on November 21, 2019
Copyright 2023 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions